Evidence map›Paper›PMID 31411871›Full record

ArticleACS nano2019

Hydrogel-Coated Microneedle Arrays for Minimally Invasive Sampling and Sensing of Specific Circulating Nucleic Acids from Skin Interstitial Fluid.

Dana Al Sulaiman, Jason Y H Chang, Nitasha R Bennett, Helena Topouzi, Claire A Higgins, Darrell J Irvine, Sylvain Ladame

Open access · greenAbstract read
In one paragraph

Article in ACS nano, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 222 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Dana Al SulaimanDepartment of Bioengineering , Imperial College London , London SW7 2AZ , United Kingdom.
Nitasha R Bennett
Helena TopouziDepartment of Bioengineering , Imperial College London , London SW7 2AZ , United Kingdom.
Claire A HigginsDepartment of Bioengineering , Imperial College London , London SW7 2AZ , United Kingdom.ORCID 0000-0002-9742-5149
Darrell J IrvineRagon Institute of MIT, MGH, and Harvard , Boston , Massachusetts 02139 , United States.ORCID 0000-0002-8637-1405
Sylvain LadameDepartment of Bioengineering , Imperial College London , London SW7 2AZ , United Kingdom.ORCID 0000-0002-3358-9638
Imperial College London · GBMassachusetts Institute of Technology · USHoward Hughes Medical Institute · US

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI MATTHEW G. VANDER HEIDEN · 1985 to 2026
$93.9M
Cancer Research UK 26141Cancer Research UK C49996/A26141NCI NIH HHS P30 CA014051
6 · The paper itself

Abstract

Minimally invasive technologies that can sample and detect cell-free nucleic acid biomarkers from liquid biopsies have recently emerged as clinically useful for early diagnosis of a broad range of pathologies, including cancer. Although blood has so far been the most commonly interrogated bodily fluid, skin interstitial fluid has been mostly overlooked despite containing the same broad variety of molecular biomarkers originating from cells and surrounding blood capillaries. Emerging technologies to sample this fluid in a pain-free and minimally-invasive manner often take the form of microneedle patches. Herein, we developed microneedles that are coated with an alginate-peptide nucleic acid hybrid material for sequence-specific sampling, isolation, and detection of nucleic acid biomarkers from skin interstitial fluid. Characterized by fast sampling kinetics and large sampling capacity (∼6.5 μL in 2 min), this platform technology also enables the detection of specific nucleic acid biomarkers either on the patch itself or in solution after light-triggered release from the hydrogel. Considering the emergence of cell-free nucleic acids in bodily fluids as clinically informative biomarkers, platform technologies that can detect them in an automated and minimally invasive fashion have great potential for personalized diagnosis and longitudinal monitoring of patient-specific disease progression.

Indexed as

Biosensing TechniquesBiomarkersCell-Free Nucleic AcidsExtracellular FluidHumansHydrogelsMinimally Invasive Surgical ProceduresNeedlesSkinBiomarkersCell-Free Nucleic AcidsHydrogelsbiomarkerhydrogelmicroneedlemicroRNAskin interstitial fluid

Identifiers

PMID31411871
PMCPMC6746174
OpenAlexW2968766074

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.